Ambroxol,the cough expectorant with neuroprotective effects  

作　　者：Kristin Patzwaldt Salvador Castaneda-Vega 

机构地区：[1]Werner Siemens Imaging Center,Department of Preclinical Imaging and Radiopharmacy,Eberhard Karls University Tuebingen,Tuebingen,Germany [2]Department of Nuclear Medicine and Clinical Molecular Imaging,University Clinic Tuebingen,Tuebingen,Germany

出　　处：《Neural Regeneration Research》2024年第11期2345-2346,共2页中国神经再生研究（英文版）

基　　金：partly funded by the Clinician-Scientist grant(No.472-0-0)by the medical faculty of the University of Tübingen(to SCV).

摘　　要：Ambroxol hydrochloride(2-amino-3,5-dibromo-N-methylbenzylamine hydrochloride)has been used as a mucolytic agent in the treatment of respiratory diseases since the late 1970s.Its effects on mucus membranes such as mucus disruption,increased mucus production,and low toxicity profile were addressed in its original German patent in 1966.These first described properties have kept Ambroxol available worldwide and over the counter in the pharmaceutical market to this day.

关 键 词：protective AGENT GERMAN 

分 类 号：R974[医药卫生—药品]